Letter from the President
Dear IMS members and Colleagues, Welcome to the new edition of our newsletter! Our 18th International Myeloma Annual Meeting in...
Read moreEditor in Chief
Evangelos Terpos, MD, PhD
Associate Editors
Mariateresa Fulciniti, PhD
Neils van de Donk, MD, PhD
Stahthis Kastritis, MD
Administrative Director
Moira Hancock
Dear IMS members and Colleagues, Welcome to the new edition of our newsletter! Our 18th International Myeloma Annual Meeting in...
Read moreThe Scientific Program Committee invites you to submit an abstract for the 19th International Myeloma Society Annual Meeting, taking place August 25-27, 2022 in Los Angeles, California. The online call for abstracts for the 19th International Myeloma Society Annual Meeting is open until May 30. Submit...
Read moreHighlights from the IMS Annual Meeting: Clinical Updates Highlights from the IMS Annual Meeting: Basic and Translational Updates
Read moreWhen he is not in the lab, Mario Boccadoro likes to ride his motorbike through the Italian Alps. In this...
Read moreMyeloma Genomics and Epigenomics The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma. Boyle...
A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma. Mei H, Li C, Jiang...
A highlight of three recent studies focused on the evaluation of epigenomic alterations in myeloma cells, which may lead to...
Read moreA 55-year-old male presented with easy bruising and recurrent nose bleeds. He had mild anemia with Hb of 7.2 mM,...
Patient has one plasmacytoma (biopsy proven) and one more lesion in the pelvis which is positive in PET/CT. The patient...
Jesús San-Miguel, MD, PhD, is professor of Medicine-Hematology and Head of Clinical and Translational Medicine at the University of Navarra,...
Read moreSubmitted by Nikhil Munshi Are you an amateur photographer? The IMS Post is inviting our readers to submit photos for...
Read more© 2021 International Myeloma Society. All Rights Reserved - Website by Rocket Marketing.
© 2021 International Myeloma Society. All Rights Reserved - Website by Rocket Marketing.